Cargando…

The mechanism of activation of monomeric B-Raf V600E

Oncogenic mutations in the serine/threonine kinase B-Raf, particularly the V600E mutation, are frequent in cancer, making it a major drug target. Although much is known about B-Raf’s active and inactive states, questions remain about the mechanism by which the protein changes between these two state...

Descripción completa

Detalles Bibliográficos
Autores principales: Maloney, Ryan C., Zhang, Mingzhen, Jang, Hyunbum, Nussinov, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215184/
https://www.ncbi.nlm.nih.gov/pubmed/34188782
http://dx.doi.org/10.1016/j.csbj.2021.06.007